Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmacyclics (PCYC) -- Ignore unavailable to you. Want to Upgrade?

To: Doug Meetmer who wrote (441)	5/11/1999 4:38:00 PM
From: Biomaven	Read Replies (1) \| Respond to of 717

One possibility (and part of the reason I bought some calls a few days back) is that there was some follow through from the H&Q conference in London today. I don't think there are any trial results on the horizon and I couldn't find anything at ASCO. They could sign a partner for Antrin or a non-US partner for Gd-Tx at any time, I suppose. As I've said often before, the price movements in this stock generally baffle me. I have no idea why we went down to 13 a few days ago, any more than I know why we have recovered now. Peter